Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,911 total articles
Joshua J. Ofman, President of GRAIL, Inc. (NASDAQ: GRAL), reported the sale of 3,827 shares of common stock for proceeds of $177,227 in a Form 4 filing with the SEC. The transactions occurred between March 5 and March 9, 2026, and were identified in the filing as automatic sell-to-cover trades to satisfy withholding taxes tied to award vesting and …
Grail Chief Executive Officer Robert P. Ragusa sold $409,245 worth of company stock in several transactions earlier this month, filings show. The sales were executed to satisfy withholding tax obligations tied to award vesting and share delivery. The equity moves come amid mixed operational results for the company, including growth in Galleri testi…
Cerus Corp's Chief Medical Officer, Richard J. Benjamin, sold 125,964 shares of company stock between March 5 and March 9, 2026, for about $202,334, while acquiring 55,220 shares at no cost on March 5. After the transactions, Benjamin directly holds 879,101 shares. The insider activity coincides with a recent 9.4% one-week share decline and follows…
Cerus Corporation's chief legal officer, Jensen Chrystal, sold 30,845 shares of common stock on March 6, 2026, for $2.0055 per share, totaling $61,859, according to a Form 4 filing. The sale lowered her direct stake in the company to 1,059,139 shares. The transaction followed an acquisition of 55,220 shares on March 5, 2026, recorded at $0.0. The s…
Cerus Corp Chief Operating Officer Vivek K. Jayaraman sold 34,094 shares on March 6, 2026 to fulfill statutory tax withholding and brokerage fees tied to restricted stock unit vesting, netting $68,375 at $2.0055 per share. The transactions followed a no-cost receipt of 80,320 shares on March 5, 2026. Cerus reported $233.8 million in revenue for Q4 …
William Mariner Greenman, President and CEO of Cerus Corp (CERS), completed an automatic sale of 78,187 shares on March 6, 2026 to satisfy tax withholding and broker fees tied to restricted stock unit vesting. The sale, at $2.0055 per share for $156,804, followed a no-cost issuance of 193,270 shares on March 5, 2026. After these filings, Greenman d…
iHeartMedia Chairman and CEO Robert W. Pittman bought 16,349 shares of Class A common stock on March 9, 2026, in a transaction valued at $48,525. The purchase was disclosed on a Form 4 filing with the SEC. The move comes after the company posted Q4 2025 revenue that beat estimates, driven by podcast growth and cost savings, even as net debt remains…
Douglas M. Pasquale, a member of Dine Brands Global's board, executed a purchase of 500 shares on March 9, 2026, for $15,000. The transaction follows a separate conversion of restricted stock units into 4,946.607 shares on March 6, 2026. These insider moves occur amid a fiscal fourth-quarter report that missed some consensus metrics while the compa…
Adaptive Biotechnologies Chief People Officer Lo Francis sold 38,074 shares on March 5, 2026, for $15.09 per share, generating $574,536 in proceeds to cover tax withholding tied to RSU vesting. The transaction leaves Francis with 321,967 directly held shares and an indirect holding of 2,500 shares through spouse You Jin Lee. Separately, Adeptus Bio…
Tosha Perkins, Chief Administrative Officer of Archer Aviation Inc. (ACHR), sold 54,786 Class A shares on March 5, 2026, generating $353,972 to satisfy tax obligations from restricted stock unit vesting. The sale occurred across multiple trades at prices between $6.315 and $6.775, with a weighted average of $6.461. Perkins retains direct ownership …
Pinterest director Rajaram Gokul sold 1,050 Class A shares on March 6, 2026, under a pre-established 10b5-1 plan, realizing $21,000 at $20.00 per share. The transaction leaves him with 29,550 directly held shares and an indirect holding of 3,957 shares through a family trust. The sale comes as the company announces a $1 billion convertible note fro…
Enrico Digirolomo, a director at Coherent Corp (NASDAQ: COHR), sold 3,911 shares of common stock on March 6, 2026, at $241.50 per share for a total of $944,506. After the sale, he directly holds 17,446 shares. The same day he donated 1,847 shares to a donor advised fund valued at $0 and exercised options to buy 1,005 and 2,906 shares. The stock has…
EchoStar CORP's Chief Legal Officer Dean Manson reported the sale of 19,031 Class A shares on March 5, 2026, for about $2.18 million, according to an SEC Form 4. The transaction occurred the same day Manson exercised options to acquire 21,631 shares at $14.04 per share. The stock has risen 291% over the past year but declined 7.4% in the prior week…
Item Second Irr. Trust FBO Kyle R. Westphal, identified as a ten percent owner of Vertex, Inc. (NASDAQ: VERX), sold 10,000 shares of Class A Common Stock on March 9, 2026, for $150,477 at a weighted average price of $15.0477. The transaction reduced a holding that still stands at 1,221,100 shares. The sale occurs as VERX trades at $14.94, down 54% …
Broadridge Financial Solutions Chief Executive Timothy C. Gokey bought 5,300 shares on March 6, 2026, in a transaction valued at $1,030,794. The move coincides with the company’s announced agreement to acquire CQG and a mix of analyst reactions that include reiterated and upgraded Buy ratings alongside trimmed price targets.
Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 10,082 shares on March 6, 2026 to meet tax obligations tied to a restricted stock vesting, while receiving 106,207 restricted shares the prior day. The company has recently reported results and guidance that prompted analyst price-target reductions and completed a sizable acquisi…
Surgery Partners Chief Executive Officer Jason Eric Evans sold 11,462 shares on March 6, 2026, for $13.79 per share, generating proceeds of $158,060 to cover tax liabilities tied to restricted stock vesting. The transactions followed a grant of 278,106 restricted shares on March 5, 2026, and leave Evans with 940,786 shares outstanding. The stock is…
Surgery Partners CFO David T. Doherty disposed of 14,574 shares on March 6, 2026, to meet tax withholding tied to newly vested restricted stock. The sale came as the company's shares trade close to a 52-week low, after a recent weekly decline. Doherty still holds 88,803 shares after the transaction. Separately, the company expanded its ambulatory f…
Arthur J. Gallagher & Co. Vice President Hudson Scott R. completed offsetting equity transactions on March 6, 2026, selling 3,800 shares for $864,766 and exercising options to acquire 3,800 shares at $79.59 for $302,442. Following the trades, Hudson holds 85,920 shares directly and 411.467 shares indirectly through the Gallagher 401(k) plan; he als…
Jane Prior, Chief Marketing Officer of The Vita Coco Company, Inc. (NASDAQ: COCO), executed a set of transactions on March 5, 2026, that included the sale of common stock worth roughly $2.6 million and the exercise of employee stock options. The trades coincided with analyst model updates following the company’s fourth-quarter results and a board a…
WhiteHorse Finance director John Bolduc bought $119,710 of the company’s common shares in transactions filed on Form 4, executed on March 5 and 6, 2026. The purchases were recorded at prices between $7.11 and $7.25 per share and bring Bolduc’s direct and indirect holdings to 272,032 shares. The trades coincide with a recent 10.4% one-week stock gai…
Mike Zoi, who holds a roughly 10% stake in Motorsport Games Inc. (MSGM), sold 144,844 Class A shares across three transactions between March 5 and March 9, 2026, for proceeds totaling $665,138. The disposals were executed under a Rule 10b5-1 plan put in place on December 31, 2025; Zoi continues to indirectly own 1,191,420 shares through Driven Life…
Joel Bender, director and president of Cactus, Inc. (WHD), sold 63,963 shares of Class A common stock on March 5, 2026, for $50.74 per share, a transaction totaling $3,245,482. The company delivered a better-than-expected Q4 2025, but its stock fell in after-hours trading amid broader market concerns and company-specific headwinds. Analysts adjuste…
Sara Kelly, Executive Vice President and Chief Partner Officer at Starbucks Corporation, sold 2,500 shares on March 5, 2026, under a pre-arranged Rule 10b5-1 plan for $242,800. After the sale she directly owns 59,608.5548 shares. The stock has risen to $99.77 and is up 20.68% over six months as the company navigates a mixed first-quarter fiscal 202…
Hamilton James C., chief medical officer at Arrowhead Pharmaceuticals (ARWR), sold 10,000 shares on March 5, 2026 under a pre-arranged 10b5-1 plan for a total of $641,900. The transaction occurred as the company reported Q1 fiscal 2026 results that beat expectations, while analysts and platform analysis flagged valuation and guidance concerns that …
